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Abstract
Background-In patients with limb girdle dystrophy the relative contribution ofperipheral factors ( (4) histopathological findings in the muscles included dystrophic lesions without an inflammatory cell infiltrate or features of metabolic or congenital myopathies. In addition, in two sporadically affected men the absence of dystrophin abnormalities excluded Duchenne and Becker muscular dystrophies. No patients had a scoliosis or any abnormality on the chest radiograph or obvious abnormalities in diaphragm placement.4 Two patients were current smokers. The duration oftheir disease was 22-2 (9) years (range .
Twenty normal subjects matched for age (range 20-70 years, 10 men) were studied as a control group.
The study was approved by the local ethics committee and subjects gave their informed consent.
FUNCTIONAL EVALUATION
Routine spirometric tests and arterial blood gas tensions obtained with subjects in a seated position were measured as previously described. 6 The normal values for lung volumes were those of the European Community for Coal and Steel.7 Maximal static inspiratory (MIP) and expiratory (MEP) pressures at residual volume (RV) and total lung capacity (TLC), respectively, measured against an obstructed mouthpiece with a small leak to minimise oral pressure artefacts, were recorded using a differential pressure transducer (Statham SC 1001). The subjects were comfortably seated, wearing a noseclip, and performed maximal inspiratory efforts maintaining maximal pressures for at least one second. The manoeuvres were repeated until three measurements with less than 5% variability were recorded, and the highest value obtained was taken for analysis. The predicted values for maximal respiratory pressures were those proposed by Black (Pco2) was sampled continuously at the mouth and measured by an infrared CO2 meter (Normocap 200, Datex). The values for dead space and resistance of the system up to a flow of 4 1/s were 178 ml and 0-92 cm H20/l/s, respectively.
The electromyographic activity (EMG) of the respiratory muscles was recorded as previously described.'2-14 The EMG of the chest wall muscles was recorded from the second parasternal intercostal muscles (EMGp) and the diaphragm (EMGd) via large surface electrodes. The EMGd was recorded from the lower anterolateral rib cage.'5 Muscle action potentials ("raw") were differentially amplified and filtered between 100 and 1000 Hz to remove as much ECG as possible without significantly filtering the EMG. The filtered EMG signal along with mouth pressure recording were displayed on a single beam storage oscilloscope (Tektronix 5115). EMG activity was full wave rectified and integrated over time (time constant 100 ms) using a third order, low pass filter to provide a measurement of change in average electrical activity as a function of time, referred to as "moving time average". 16 Inspiratory activity was quantified both as peak of activity (XP) and as rate of rise of activity (XP/TI). The former was directly measured in arbitrary units and the latter was obtained by dividing it by the inspiratory time.
Because of the variability of the impedance between diaphragm and electrodes, absolute values (mV) are not comparable among different subjects. To overcome this problem and to obtain a reference value, EMG activity was measured while the subject, connected to the pneumotachograph, performed an inspiratory capacity (IC) manoeuvre breathing in up to the total lung capacity (TLC). '2-'4 This was repeated at least three times and in each subject the intensity of the recorded diaphragmatic EMG was closely reproducible (less than 5% variability). The mean level of this EMG activity was taken as a reference; all successive measurements have been expressed as a percentage of this reference value obtained at TLC. As EMG activity of an inspiratory muscle may include cardiac muscle activity, we checked cardiac artefacts by manually gating the ECG, when necessary, so that it would not contribute to the EMG. EMG data in the text and tables are expressed in terms of rate of rise of activity.
The output of the CO2 meter, flow signal, integrated flow signal, mouth pressure, and the moving time average were recorded continuously on a multichannel chart recorder. After a 10 minute adaptation period, baseline evaluation began. Respiratory cycles, occlusions, and EMG were continuously recorded for 10 minutes and the cycles following occlusions discarded. Average values for each subject are presented. Subsequently, the subjects underwent a CO2 rebreathing test.'7 A gas mixture (7% CO2, 93% 02) was inhaled for 3-4 minutes and the sampled gas was returned to the rebreathing bag. Rebreathing started after 30-45 seconds which allowed the subject to equilibrate with the circuit, as shown by the plateau on the CO2 recording and minimal both conditions resulting in an increased respiratory drive which maintains VTM constant. Based on those observations, in patients in whom loss of VC disproportionate to the decrease in respiratory muscle strength may suggest abnormalities in elastic properties of the lung,20 a relatively normal VT/TI would suggest an increased neural respiratory drive. It is also possible that the decrease in A(VT/TI)/APcO2 reflects a decrease in respiratory muscle strength rather than a low neural respiratory drive. Although this could not be totally excluded in the present investigation, no significant relation was found between A(VT/T)/ APco2 and respiratory muscle strength. In fact, in the patients with a low VT/TI response, the respiratory muscle strength was similar to that observed in those with a normal VT/TI response (34-11 (10-7)% versus 36-9% (12d15)%).
The explanation of a markedly low APO/ APco2 is not clear. It is unlikely that, in the circumstances ofthe present study, the decrease in respiratory muscle strength could be the reason for the low APO.1/APco2. In fact, the Po.1 response to carbon dioxide did not relate to muscle weakness.
A clue might be the measurement of Po.1, the phase lag between pressure and flow and the shape of the driving pressure being some of the factors which should be considered in evaluating Po.1 as an index of respiratory drive.
Phase lag between pressure and flow may occur as a consequence of resistance just at the end of expiration. This may be due to abnormal function of the upper airway muscles which is common in neuromuscular disease. ' 
